Shedding light on a Fat-Related protein after stomach surgery
NCT ID NCT07335549
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 40 people with severe obesity who had laparoscopic sleeve gastrectomy, a type of weight-loss surgery. Researchers measured levels of a protein called isthmin in the blood before surgery and three months after. The goal was to see if isthmin, which is linked to metabolism and appetite, changes after significant weight loss. The study is purely observational and does not test any drug or treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could clarify how isthmin levels change after weight-loss surgery, pointing toward new ways to understand or treat obesity-related metabolic issues.
What could go wrong
This is a small, completed observational study with only 40 participants. It measures a biomarker (isthmin) and does not test a treatment, so it cannot directly lead to a therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Elazig Fethi Sekin City Hospital
Elâzığ, 23100, Turkey (Türkiye)